NCT02682849View on ClinicalTrials.gov

Active Clearance Technology (ACT) Registry

CompletedOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

May 10, 2016

Primary Completion Date

May 31, 2018

Study Completion Date

March 31, 2020

Conditions

Retained Blood Syndrome

Trial Locations (1)

55905

Mayo Clinic, Rochester

All Listed Sponsors

lead

John M. Stulak

OTHER

NCT02682849 - Active Clearance Technology (ACT) Registry | Biotech Hunter | Biotech Hunter